Across TCGA pan-cancer cohorts, MIR129-2 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MIR129-2 data layer compared with 6 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher MIR129-2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MIR129-2 expression acts as an unfavorable survival marker.

ESCA are the cancer types where MIR129-2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	All	0.198	0.872	.003	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: MIR129-2 tumor-vs-normal RNA expression · all MIR129-2 data types